THEOPHYLLINE - ANVISA Registration 80254180409

Access comprehensive regulatory information for THEOPHYLLINE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80254180409 and manufactured by MICROGENICS CORPORATION. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until Apr 18, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including ROCHE DIAGNOSTICS GMBH, ORTHO CLINICAL DIAGNOSTICS, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.